Dongkoo re-launches cernitin flower pollen product

Published: 2012-07-27 06:56:00

Updated: 2012-07-27 06:56:00

Dongkoo Pharmaceutical says that Cernilton capsule, an over-the-counter drug, which is effective for the treatment of chronic prostatitis and prostatodynia, has been re-marketed since June to meet growing market demand.

Cernilton was released 20 years ago, but its sales were discontinued due t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK